|
EPR Podcast Ep 26 – Navigating Nitrosamine Impurities
|
|
0
|
391
|
June 26, 2024
|
|
Predicting Nitrosamine Formation in the Solid State
|
|
3
|
834
|
June 24, 2024
|
|
Common Template for initial assessment of Nitrosamine impurities
|
|
0
|
693
|
June 20, 2024
|
|
Insights from the Lhasa Limited and IPEC Europe Nitrites collaborative meeting
|
|
1
|
558
|
June 16, 2024
|
|
🇲🇽 Conferencia USP Nitrosaminas en México presencial 21-Marzo
|
|
4
|
791
|
May 27, 2024
|
|
Managing the complexities of NDSRI method development: The N-nitroso propranolol case story
|
|
0
|
558
|
May 14, 2024
|
|
Using the Carcinogenicity Potency Categorization Algorithm to Predict N-Nitrosamine Carcinogenicity -Webinar
|
|
0
|
381
|
May 13, 2024
|
|
🇺🇸 FDA CDER Generic Drug Forum (GDF) 2024
|
|
5
|
1428
|
April 14, 2024
|
|
📅 Ascorbic Acid And Alpha-Tocopherol As Nitrite Scavengers - An Elegant And Simple Solution To Mitigate Nitrosamines In Drug Products -Event
|
|
0
|
922
|
April 5, 2024
|
|
USP User Forum in 🇨🇦 Toronto
|
|
0
|
246
|
March 12, 2024
|
|
Read-across Masterclass: How To Facilitate Your Acceptable Intake Limit Setting For Nitrosamines
|
|
0
|
386
|
March 7, 2024
|
|
HESI Open call to Q(SAR) and QM working group
|
|
3
|
798
|
February 20, 2024
|
|
TALK SERIES: Navigating Nitrosamine and NDSRIs regulations with Dr. Reddy´s Laboratories
|
|
1
|
788
|
February 11, 2024
|
|
Exploring the CPCA Framework: Defining Acceptable Intake for NDSRIs -Event
|
|
2
|
908
|
January 10, 2024
|
|
Upcoming and recorded Lhasa webinars
|
|
3
|
929
|
December 21, 2023
|
|
Nitrosamine Impurities Deadline: Are Your Products Compliant?
|
|
6
|
713
|
December 6, 2023
|
|
8th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
1
|
1088
|
December 1, 2023
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
532
|
November 30, 2023
|
|
Free Webinar: Nitrosamines in Drug Products
|
|
12
|
1937
|
November 16, 2023
|
|
Nitrosamine Risk Reduction In Pharmaceutical Formulations Webinar
|
|
1
|
895
|
November 6, 2023
|
|
USP, EDQM, JP, IPC through Pharmacopeial Discussion Group on Nitrosamines
|
|
2
|
520
|
November 2, 2023
|
|
FDA - Pharmaceutical Quality Symposium
|
|
1
|
845
|
November 1, 2023
|
|
Useful interactive vedios on Nitrosamines Impuririties
|
|
2
|
425
|
November 1, 2023
|
|
Post any educational in-person event here!
|
|
2
|
798
|
November 9, 2023
|
|
Personal perspective on N-Nitrosamines and recent revision of guidelines
|
|
7
|
819
|
October 27, 2023
|
|
PAQ Experts Forum on Handling Nitrosamines & NDSRIs in Pharmaceuticals - to be held in Ahmedabad, Gujarat on 27th October, 2023
|
|
1
|
458
|
October 23, 2023
|
|
The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)
|
|
1
|
668
|
October 22, 2023
|
|
AAM GRx + Biosims 2023 -Event
|
|
5
|
569
|
October 16, 2023
|
|
Managing Nitrite Impurities: A Combined Supplier-Manufacturer View to Nitrosamine Risks
|
|
3
|
1080
|
October 3, 2023
|
|
Uso de herramientas in-silico para Nitrosaminas
|
|
0
|
430
|
October 2, 2023
|